Cargando…
Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy
Human bone marrow-derived mesenchymal stem cells (hBMSCs) are promising candidates for stem cell therapy in clinical trials. Applications of hBMSCs in clinical therapy are limited by cellular senescence due to long-term ex vivo expansion. Metformin, an oral hypoglycemic drug for type 2 diabetes, has...
Autores principales: | Ye, Pingting, Feng, Lei, Zhang, Dan, Li, Ruihao, Wen, Yixuan, Tong, Xiaohan, Shi, Shuo, Dong, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079386/ https://www.ncbi.nlm.nih.gov/pubmed/37035446 http://dx.doi.org/10.1155/2023/1429642 |
Ejemplares similares
-
High Glucose Induces Bone Marrow-Derived Mesenchymal Stem Cell Senescence by Upregulating Autophagy
por: Chang, Tzu-Ching, et al.
Publicado: (2015) -
Metformin Ameliorates Senescence of Adipose-Derived Mesenchymal Stem Cells and Attenuates Osteoarthritis Progression via the AMPK-Dependent Autophagy Pathway
por: Li, Zheng, et al.
Publicado: (2022) -
Curcumin Alleviates the Senescence of Canine Bone Marrow Mesenchymal Stem Cells during In Vitro Expansion by Activating the Autophagy Pathway
por: Deng, Jiaqiang, et al.
Publicado: (2021) -
Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy
por: Zhao, K, et al.
Publicado: (2015) -
Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD-induced obese mice
por: Li, Min, et al.
Publicado: (2017)